Is Dapagliflozin a Cardiac Anti-Aging Drug?

JACC Heart Fail. 2023 Mar;11(3):305-306. doi: 10.1016/j.jchf.2022.10.008. Epub 2022 Dec 7.

Authors

Antoni Bayes-Genis¹, Julio Núñez²

Affiliations

¹ Heart Institute, Hospital Universitari Germans Trias I Pujol, CIBERCV, Badalona, and the Universitat Autonoma Barcelona, Badalona, Spain. Electronic address: abayesgenis@gmail.com.
² Servicio de Cardiología, Hospital Clínico, INCLIVA, Valencia, Spain.

PMID: 36647928
DOI: 10.1016/j.jchf.2022.10.008

No abstract available

Keywords: SGLT2 inhibitors; aging; dapagliflozin.

Publication types

Editorial
Comment

MeSH terms

Aging
Benzhydryl Compounds / therapeutic use
Diabetes Mellitus, Type 2*
Glucosides / therapeutic use
Heart Failure*
Humans

Substances

dapagliflozin
Benzhydryl Compounds
Glucosides